Author(s):
Harshada Kailas Patil, Amitkumar R. Dhankani, Mansi A. Dhankani, Sunil P. Pawar
Email(s):
patilharshada1782001@gmail.com
DOI:
10.52711/2231-5675.2025.00047 
Address:
Harshada Kailas Patil*, Amitkumar R. Dhankani, Mansi A. Dhankani, Sunil P. Pawar
P.S.G.V.P Mandal’s College of Pharmacy, Shahada, Dist – Nandurbar- 425409 Maharashtra India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 4,
Year - 2025
ABSTRACT:
A new, accurate and precise High performance liquid chromatography method have been developed for the estimation of Safinamide Mesylate in bulk drug and pharmaceutical dosage form. The chromatographic separation was carried out on Agilent poroshell C18 (150 mm X 4.6 mm i.d.) 5µm column using a mixture of Acetonitrile: 0.1% TFAA in Water (70:30) as a mobile phase at a flow rate of 1.0 ml/min, the detection as carried out at 226 nm. The retention time of Safinamide Mesylate was 2.63 respectively. The method produced linear responses in the concentration range of 15.0 -45.0 µg/ml of Safinamide Mesylate. The LOD and LOQ was found to be LOD = 0.259 µg/mL and LOQ = 0.785 µg/mL for Safinamide Mesylate respectively. The accuracy of method was validated by recovery studies and found to be significant within acceptable range 98.0-102.0%. The developed RP-HPLC method is found to be accurate, precise, linear and robust. The present work is successfully developed and validated as per ICH guidelines. The proposed method provides accurate and precise quality control tool for routine of Safinamide Mesylate in bulk and in pharmaceutical dosage form.
Cite this article:
Harshada Kailas Patil, Amitkumar R. Dhankani, Mansi A. Dhankani, Sunil P. Pawar. Analytical Method Development and Validation for Estimation of Safinamide Mesylate by RP-HPLC in Bulk Drug and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2025; 15(4):300-5. doi: 10.52711/2231-5675.2025.00047
Cite(Electronic):
Harshada Kailas Patil, Amitkumar R. Dhankani, Mansi A. Dhankani, Sunil P. Pawar. Analytical Method Development and Validation for Estimation of Safinamide Mesylate by RP-HPLC in Bulk Drug and Pharmaceutical Dosage Form. Asian Journal of Pharmaceutical Analysis. 2025; 15(4):300-5. doi: 10.52711/2231-5675.2025.00047 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2025-15-4-9
REFERENCES:
1. Pringsheim T, Jette N, Frolkis A. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014; 29(13): 1583–1590.
2. Harshada Kailas Patil, et, al. Safinamide Mesylate: Analytical and Chromatographic Methodologies. Asian Journal of Pharmaceutical Analysis. 2025; 15(2): 1-7.
3. Dusakanti Akhila, Pasupuleti Sunitha, Vijaya Kuchana. Stability indicating RP-HPLC analytical method development and validation for the estimation of safinamide in bulk and marketed pharmaceutical dosage form. International Journal of Multidisciplinary Research and Growth Evaluation. 2024; 5(1): 93-99.
4. V. Shirisha, Gurram Srikanth, Santhosh Illendula, K. Rajeswar Dutt. RP-HPLC method development and validation for the Estimation of safinamide in api form and marketed Formulation. International Journal of Research. 2021; X(II): 402-417.
5. Miller LC. An International Pharmacopoeia. Food Drug Cosm. LJ. 1953; 8: 293.
6. Heyman ML, Williams RL, USP Council of the convention section on global public health. Ensuring global access to quality medicines: Role of the US Pharmacopeia. Journal of Pharmaceutical Sciences. 2011; 100(4):1280-1287.
7. Barbulovic-Nad I, Lucente M, Sun Y, Zhang M, Wheeler AR, Bussmann M. Bio-microarray fabrication techniques—a review. Critical Reviews in Biotechnology. 2006; 26(4): 237-59.
8. Armstrong DW. Pseudophase liquid chromatography: applications to TLC. Journal of Liquid Chromatography. 1980; 3(6): 895-900.
9. Bose, A. HPLC calibration process parameters in terms of system suitability test. Austin Chromatography. 2014; 1(2): 1-4.
10. Sabir, A.M. HPLC method development and validation -a review. International Research Journal of Pharmacy. 2013; 4(4): 39-46.